Internal Medicine, Nephrology · Roseburg, OR
NPI
1003813015
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2410 NW Edenbower Blvd Ste 176
Roseburg, OR, 97471
Phone (541) 957-1133
Groups this clinician bills Medicare through
Medicare paid, 2024
$641K
39,809 services
Medicare patients, 2024
720
Average age 75
Drug cost, 2024
$860K
9,624 prescriptions
Company payments, 2025
$30K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil Kumar was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 19,380 times for 85 patients. In total Neil Kumar billed 39,809 services in 29 codes, and Medicare paid $641K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 19,380 | 85 | $6.38 | $124K |
| J0897 Injection, denosumab, 1 mg | Office | 9,960 | 104 | $20.31 | $202K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 4,800 | 57 | $2.33 | $11K |
| 99213 Office E&M - Established | Office | 1,800 | 624 | $64.73 | $117K |
| 96372 Injection Administration | Office | 788 | 186 | $11.62 | $9,159 |
| 90970 ESRD Related Services (not dialysis) | Office | 754 | 20 | $7.57 | $5,707 |
| 99232 Hospital E&M - Subsequent | Facility | 549 | 89 | $61.77 | $34K |
| 85018 Blood Count | Office | 468 | 212 | $2.32 | $1,086 |
| 90960 ESRD Related Services (not dialysis) | Office | 343 | 49 | $283.64 | $97K |
| 81002 Clinical Chemistry | Office | 125 | 97 | $3.41 | $426 |
| 99203 Office E&M - New | Office | 78 | 78 | $77.35 | $6,033 |
| 99223 Hospital E&M - Initial | Facility | 61 | 53 | $134.32 | $8,194 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 54 | 54 | $70.34 | $3,799 |
| 82570 Clinical Chemistry | Office | 51 | 51 | $5.08 | $259 |
| 99222 Hospital E&M - Initial | Facility | 49 | 35 | $95.31 | $4,670 |
By year: 2022 $734K for 43,400 services; 2023 $644K for 39,397 services; 2024 $641K for 39,809 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 468 | 212 | $2.32 | $1,086 |
| 81002 Clinical Chemistry | 125 | 97 | $3.41 | $426 |
| 82570 Clinical Chemistry | 51 | 51 | $5.08 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Neil Kumar prescribed most often to Medicare patients was Potassium Chloride, with 1,033 prescriptions and refills. In total Neil Kumar wrote 9,624 Medicare prescriptions that cost $860K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Chloride Generic | 1,033 | 1,714 | 276 | $16K |
| Furosemide Generic | 844 | 1,516 | 244 | $4,571 |
| Calcitriol Generic | 603 | 1,155 | 156 | $5,790 |
| Bumetanide Generic | 591 | 841 | 144 | $30K |
| Losartan Potassium Generic | 555 | 1,092 | 165 | $6,412 |
| Clonidine Hcl Generic | 389 | 625 | 107 | $4,538 |
| Gabapentin Generic | 306 | 484 | 75 | $2,880 |
| Pantoprazole Sodium Generic | 234 | 433 | 70 | $2,692 |
| Tamsulosin Hcl Generic | 226 | 466 | 61 | $3,735 |
| Prosol Parenteral Amino Acid 20% No.1 | 222 | 222 | Under 11 | $24K |
| Lisinopril Generic | 212 | 437 | 54 | $1,486 |
| Allopurinol Generic | 204 | 409 | 53 | $1,653 |
| Midodrine Hcl Generic | 189 | 246 | 65 | $9,368 |
| Spironolactone Generic | 156 | 245 | 40 | $1,269 |
| Amlodipine Besylate Generic | 156 | 298 | 45 | $1,019 |
Brand drugs: 1,280 claims; generic drugs: 8,332 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil Kumar $30K ($20K in general payments such as food, travel and fees and $10K for research) from 24 companies. The largest payer was Hoffmann-La Roche Limited with $10K.
| Company | Payments | Amount |
|---|---|---|
| Hoffmann-La Roche Limited ROG.SW | 1 | $10K |
| Travere Therapeutics, Inc. TVTX | 12 | $5,197 |
| Ardelyx, Inc. ARDX | 11 | $5,193 |
| Sobi, Inc SOBI.ST | 5 | $4,855 |
| Amgen Inc. AMGN | 13 | $3,466 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $310 |
| Madrigal Pharmaceuticals MDGL | 7 | $217 |
| Novo Nordisk Inc NVO | 9 | $207 |
| Akebia Therapeutics Inc AKBA | 4 | $133 |
| Mallinckrodt Hospital Products Inc. | 4 | $88.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.